Viz.ai at HCMS & HFSA 2023

Viz.ai has developed Cardiology Solutions that are impacting cardiovascular care pathways through AI algorithms, streamlined workflows, and care coordination, leading to improved patient access to treatment.

Learn more about the AI-powered care coordination built for cardiovascular disease states, including:

• Hypertrophic cardiomyopathy
• Cryptogenic stroke
• Heart failure
• Cardiomyopathies
• Structural heart (patent foramen ovale, aortic stenosis)
• Pulmonary embolism
• Aortic diseases (AAA and aortic dissection)
• Arrhythmias including Atrial Fibrillation

Detecting disease off of CT, MRI, Echocardiogram, ECG and EMR data with 10 FDA-cleared AI algorithms.

Stop by the Emerging Innovations Row at HFSA to learn how Viz.ai is supporting the HERMES Trial through access to Viz Recruit, a software which alerts the study team of potential clinical trial candidates curated through AI-powered recruitment. Viz makes it easy for research teams to pre-screen potentially eligible patients coupled with easy follow up across devices.